© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
November 14, 2019
The US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.
Highlights of breast cancer advances at the ESMO Congress.
November 05, 2019
Researchers look at cost estimates stratified by stage, histology, and level of treatment.
October 28, 2019
This year has seen many advances in immunotherapy. Here is a look at some of the most significant research.